Cited by 136Sirtuins and Resveratrol in MedicineGut microbiota and healthPhytochemicals and Antioxidant Activities

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota

Open access

Bird, Julia K, Raederstorff, Daniel, Weber, Peter, Steinert, Robert E·2017·Advances in Nutrition

Open this paper in CoChat — free account Open PDF

Abstract

Encouraging scientific research into the health effects of dietary bioactive resveratrol has been confounded by its rapid first-pass metabolism, which leads to low in vivo bioavailability. Preliminary studies have shown that resveratrol can modulate gut microbiota composition, undergo biotransformation to active metabolites via the intestinal microbiota, or affect gut barrier function. In rodents, resveratrol can modify the relative Bacteroidetes:Firmicutes ratio and reverse the gut microbial dysbiosis caused by a high-fat diet. By upregulating the expression of genes involved in maintaining tight junctions between intestinal cells, resveratrol contributes to gut barrier integrity. The composition of the gut microbiome and rapid metabolism of resveratrol determines the production of resveratrol metabolites, which are found at greater concentrations in humans after ingestion than their parent molecule and can have similar biological effects. Resveratrol may affect cardiovascular risk factors such as elevated blood cholesterol or trimethylamine N-oxide concentrations. Modulating the composition of the gut microbiota by resveratrol may affect central energy metabolism and modify concentrations of satiety hormones to produce antiobesity effects. Encouraging research from animal models could be tested in humans.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3945/an.117.016568

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,700
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
An integrated catalog of reference genes in the human gut microbiome
MetaHIT Consortium, Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., Arumugam, M., Kultima, J. R., Prifti, E., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2942 · Cited by 2,164
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,893
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation
Surh, Y., Chun, K., Cha, H.-H., Han, S. S., Keum, Y., Park, K.-K., & Lee, S. S. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content
Rothwell, J. A., Pérez‐Jiménez, J., Neveu, V., Medina‐Remón, A., M'hiri, N., Garcia-Lobato, P., Manach, C., Knox, C., Eisner, R., Wishart, D. S., et al. (2013) · Database · doi:10.1093/database/bat070 · Cited by 936
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 827
Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide
Romano, K. A., Vivas, E. I., Amador-Noguez, D., & Rey, F. E. (2015) · mBio · doi:10.1128/mbio.02481-14 · Cited by 777
Resveratrol Attenuates Trimethylamine- N -Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
Chen, M.-L., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., Zhu, J.-D., Zhang, Q.-Y., & Mi, M.-T. (2016) · mBio · doi:10.1128/mbio.02210-15 · Cited by 754 · cited 4×
“A study conducted in outbred mice showed that 4 g resveratrol/kg caused gut microbiota remodeling with an increase in the relative abundance of Bacteroides, Lactobacillus, Bifidobacterium, and Akkermansia, and decreases in Prevotella, Ruminococcaceae, Anaerotruncus, Alistipes,Helicobacter, and Peptococcaceae (29).”
BackgroundInfluential
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41
Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 745
Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine
Williams, B. B., Van Benschoten, A. H., Cimermancic, P., Donia, M. S., Zimmermann, M., Taketani, M., Ishihara, A., Kashyap, P. C., Fraser, J. S., & Fischbach, M. A. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.001 · Cited by 732
A Catalog of Reference Genomes from the Human Microbiome
The Human Microbiome Jumpstart Reference Strains Consortium, Nelson, K. E., Weinstock, G. M., Highlander, S. K., Worley, K. C., Creasy, H. H., Wortman, J. R., Rusch, D. B., Mitreva, M., Sodergren, E., et al. (2010) · Science · doi:10.1126/science.1183605 · Cited by 702
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 695
Metabolism and bioavailability oftrans-resveratrol
Wenzel, E., & Somoza, V. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500010 · Cited by 677
Gut Microbiota and Its Possible Relationship With Obesity
DiBaise, J. K., Zhang, H., Crowell, M. D., Krajmalnik‐Brown, R., Decker, G. A., & Rittmann, B. E. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.460 · Cited by 616
Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Self-citation
Calorie restriction in humans: An update
Most, J., Tosti, V., Redman, L. M., & Fontana, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.005 · Cited by 530
Trimethylamine N-oxide: the good, the bad and the unknown.
Velasquez, M., Ramezani, A., Manal, A., & Raj, D. (2016) · Toxins · doi:10.3390/toxins8110326 · Cited by 504
Specific Structural Determinants Are Responsible for the Antioxidant Activity and the Cell Cycle Effects of Resveratrol
Stivala, L. A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L. C., Maga, G., Forti, L., PAGNONI, U. M., Albini, A., Prosperi, E., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101846200 · Cited by 496
The gut microbiota and its relationship to diet and obesity
Clarke, S. F., Murphy, E. F., Nilaweera, K. N., Ross, R. P., Shanahan, F., O’Toole, P. W., & Cotter, P. D. (2012) · Gut Microbes · doi:10.4161/gmic.20168 · Cited by 474
Differences in gut microbiota composition between obese and lean children: a cross-sectional study
Bervoets, L., Hoorenbeeck, K. V., Kortleven, I., Noten, C. V., Hens, N., Vael, C., Goossens, H., Desager, K., & Vankerckhoven, V. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-10 · Cited by 467
Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Zamora‐Ros, R., Knaze, V., Rothwell, J. A., Hémon, B., Moskal, A., Overvad, K., Tjønneland, A. M., Kyrø, C., Fagherazzi, G., Boutron‐Ruault, M., et al. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0950-x · Cited by 465
Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats
Etxeberria, U., Arias, N., Boqué, N., Macarulla, M. T., Portillo, M. P., Martínez, J. A., & Milagro, F. I. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.01.002 · Cited by 446 · cited 2×
“as well as Gracilibacter thermotolerans and Parabacteroides distasonis were also suppressed by resveratrol compared with the control diet (36).”
Background
Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions.
Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Si, K., & Kuwahara, A. (2008) · PubMed · Cited by 406
In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota
Bode, L. M., Bunzel, D., Huch, M., Cho, G., Ruhland, D., Bunzel, M., Bub, A., Franz, C. M. A. P., & Kulling, S. E. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.049379 · Cited by 404
Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity
Qiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., & Le, G. (2014) · Food & Function · doi:10.1039/c3fo60630a · Cited by 367
Effect of a Low Dose of Dietary Resveratrol on Colon Microbiota, Inflammation and Tissue Damage in a DSS-Induced Colitis Rat Model
Larrosa, M., Yañéz-Gascón, M. J., Selma, M. V., González-Sarrías, A., Toti, S., Cerón, J. J., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803638d · Cited by 365
Bioavailability oftrans-resveratrol from red wine in humans
Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C., Caporaso, N., Vescovi, P. P., Fogliano, V., & Marchelli, R. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500002 · Cited by 319
Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans
Randrianarisoa, E., Lehn-Stefan, A., Wang, X., Hoene, M., Peter, A., Heinzmann, S. S., Zhao, X., Königsrainer, I., Königsrainer, A., Balletshofer, B., et al. (2016) · Scientific Reports · doi:10.1038/srep26745 · Cited by 296
The Microbiome and Risk for Obesity and Diabetes
Komaroff, A. L. (2016) · JAMA · doi:10.1001/jama.2016.20099 · Cited by 296
The microbiome quality control project: baseline study design and future directions
Sinha, R. R., Abnet, C. C., White, O. R., Knight, R. D., & Huttenhower, C. (2015) · Genome biology · doi:10.1186/s13059-015-0841-8 · Cited by 284
Gut microbiota and GLP-1
Everard, A., & Cani, P. D. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9288-6 · Cited by 279
Intestinal Microbiota‐Generated Metabolite Trimethylamine‐ N‐ Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort
Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Movahed, A., Nabipour, I., Louis, X. L., Thandapilly, S. J., Yu, L., Kalantarhormozi, M., Rekabpour, S. J., & Netticadan, T. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/851267 · Cited by 265
Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum
Hsieh, C.-Y., Osaka, T., Moriyama, E., Date, Y., Kikuchi, J., & Tsuneda, S. (2015) · Physiological Reports · doi:10.14814/phy2.12327 · Cited by 255
Antimicrobial activity and effects of resveratrol on human pathogenic bacteria
Paulo, L., Ferreira, S. M. P., Gallardo, E., Queiroz, J. A., & Domingues, F. (2010) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-010-0325-7 · Cited by 228
Improved glucose homeostasis in obese mice treated with resveratrol is associated with alterations in the gut microbiome
Sung, M. M., Kim, T. T., Denou, E., Soltys, C.-L. M., Hamza, S. M., Byrne, N. J., Masson, G., Park, H., Wishart, D. S., Madsen, K. L., et al. (2017) · Diabetes · doi:10.2337/db16-0680 · Cited by 204 · cited 4×
“In one study in mice with the use of a 23 2 factorial design [standard diet, standard diet and resveratrol, high-fat and high-sucrose (HFS) diet, and HFS diet and resveratrol], 4 g resveratrol/kg affected the gut microbiome only in mice fed the obesogenic diet; resveratrol had no effect in mice fed the standard diet (…”
BackgroundMethodInfluential
Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
Chen, F., Wen, Q., Jiang, J., Li, H.-L., Tan, Y.-F., Li, Y.-H., & Zeng, N.-K. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.031 · Cited by 186
Resistant starch can improve insulin sensitivity independently of the gut microbiota
Bindels, L. B., Muñoz, R. R. S., Neto, J. C. G., Mutemberezi, V., Martínez, I., Salazar, N., Cody, E. A., Quintero, M., Kittana, H., Reyes‐Gavilán, C. G. D. L., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0230-5 · Cited by 181
Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets
Rotchés-Ribalta, M., Andrés‐Lacueva, C., Estruch, R., Escribano, E., & Urpí-Sardà, M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.08.001 · Cited by 177
Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice
Jung, M., Lee, J., Shin, N., Kim, M., Hyun, D., Yun, J., Kim, P. S., Whon, T. W., & Bae, J. (2016) · Scientific Reports · doi:10.1038/srep30887 · Cited by 174
Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control
Dao, T.-M. A., Waget, A., Klopp, P., Sérino, M., Vachoux, C., Pechère, L., Drucker, D. J., Champion, S., Barthélemy, S., Barra, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020700 · Cited by 168
Significance of wine and resveratrol in cardiovascular disease: French paradox revisited.
Vidavalur, R., Otani, H., Singal, P. K., & Maulik, N. (2006) · PubMed Central · Cited by 155
Gut microbiota composition in relation to the metabolic response to 12-week combined polyphenol supplementation in overweight men and women
Most, J., Penders, J., Lucchesi, M., Goossens, G. H., & Blaak, E. E. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.89 · Cited by 141
Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial
Timmers, S., de Ligt, M., Phielix, E., van de Weijer, T., Hansen, J., Moonen‐Kornips, E., Schaart, G., Kunz, I., Hesselink, M. K. C., Schrauwen‐Hinderling, V. B., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0499 · Cited by 139
Protective Capacity of Resveratrol, a Natural Polyphenolic Compound, against Deoxynivalenol-Induced Intestinal Barrier Dysfunction and Bacterial Translocation
Ling, K. H., Wan, M. L. Y., El-Nezami, H. S., & Wang, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00001 · Cited by 135
Hypothalamic Angptl4/Fiaf Is a Novel Regulator of Food Intake and Body Weight
Kim, H.-K., Youn, B., Shin, M.-S., NamKoong, C., Park, K. H., Baik, J., Kim, J. B., Park, J., Lee, K., Kim, Y., et al. (2010) · Diabetes · doi:10.2337/db10-0145 · Cited by 134
Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
van der Made, S. M., Plat, J., & Mensink, R. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118393 · Cited by 131
Regulation of Food Intake Through Hypothalamic Signaling Networks Involving mTOR
Woods, S. C., Seeley, R. J., & Cota, D. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155505 · Cited by 125
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial
Thazhath, S. S., Wu, T., Bound, M. J., Checklin, H. L., Standfield, S., Jones, K. L., Horowitz, M., & Rayner, C. K. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.117440 · Cited by 125
Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery
Brown, J. M., & Hazen, S. L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.765388 · Cited by 108
Regioselective Sulfation and Glucuronidation of Phenolics: Insights into the Structural Basis
Wu, B., Basu, S., Meng, S., Wang, X., & Hu, M. (2011) · Current Drug Metabolism · doi:10.2174/138920011797470100 · Cited by 107
Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol
Jin, J., Kitahara, M., Sakamoto, M., Hattori, M., & Benno, Y. (2009) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.016774-0 · Cited by 104
Resveratrol Protects Oxidative Stress-Induced Intestinal Epithelial Barrier Dysfunction by Upregulating Heme Oxygenase-1 Expression
Wang, N., Han, Q., Wang, G., Ma, W.-P., Wang, J., Wu, W., Guo, Y., Liu, L., Jiang, X., Xie, X., et al. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4184-4 · Cited by 97
Resveratrol in metabolic health: an overview of the current evidence and perspectives
Poulsen, M. M., Jørgensen, J. O. L., Jessen, N., Richelsen, B., & Pedersen, S. B. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12141 · Cited by 94
Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure
Sung, M. M. Y., Byrne, N. J., Robertson, I. M., Kim, T. T., Samokhvalov, V., Levasseur, J. L., Soltys, C.-L. M., Fung, D., Tyreman, N., Denou, E., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00455.2016 · Cited by 88
Interaction of dietary resveratrol with animal-associated bacteria
Jung, C. M., Heinze, T. M., Schnackenberg, L. K., Mullis, L. B., Elkins, S. A., Elkins, C. A., Steele, R. S., & Sutherland, J. B. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01691.x · Cited by 86
Inhibitors from Rhubarb on Lipopolysaccharide-Induced Nitric Oxide Production in Macrophages: Structural Requirements of Stilbenes for the Activity
Kageura, T., Matsuda, H., Morikawa, T., Toguchida, I., Harima, S., Oda, M., & Yoshikawa, M. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00093-1 · Cited by 81
First evidence of a membrane‐bound, tyramine and β‐phenylethylamine producing, tyrosine decarboxylase in Enterococcus faecalis: A two‐dimensional electrophoresis proteomic study
Pessione, E., Pessione, A., Lamberti, C., Coïsson, D. J., Riedel, K., Mazzoli, R., Bonetta, S., Eberl, L., & Giunta, C. (2009) · PROTEOMICS · doi:10.1002/pmic.200800780 · Cited by 72
Terpenoids and bisbibenzyls from Chinese liverwortsConocephalumconicumandDumortierahirsuta
Lu, Z., Fan, P.-H., Ji, M., & Lou, H. (2006) · Journal of Asian Natural Products Research · doi:10.1080/1028602042000325537 · Cited by 71
Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis
Wilson, A., McLean, C., & Kim, R. B. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000274 · Cited by 71
Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment
Korsholm, A. S., Kjær, T. N., Ørnstrup, M. J., & Pedersen, S. B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030554 · Cited by 71
Bioconversion of (−)-Epicatechin, (+)-Epicatechin, (−)-Catechin, and (+)-Catechin by (−)-Epigallocatechin-Metabolizing Bacteria
Takagaki, A., & Nanjo, F. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00813 · Cited by 70
The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol
Matsuoka, A., Takeshita, K., Furuta, A., Ozaki, M., Fukuhara, K., & Miyata, N. (2002) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(02)00211-5 · Cited by 70
Dietary factors and lung function in the general population: wine and resveratrol intake
Siedliński, M., Boer, J. M. A., Smit, H. A., Postma, D. S., & Boezen, H. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00184110 · Cited by 65
Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method
Rotchés-Ribalta, M., Urpí-Sardà, M., Llorach, R., Boto‐Ordóñez, M., Jáuregui, O., Chiva‐Blanch, G., Pérez‐García, L., Jaeger, W., Guillén, M., Corella, D., et al. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.09.093 · Cited by 60
Molecular mechanisms underlying nutrient detection by incretin-secreting cells
Reimann, F. M. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.11.014 · Cited by 58
Safety of resveratrol with examples for high purity, trans‐resveratrol, resVida≫
Edwards, J. A., Beck, M., Riegger, C., & Bausch, J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05855.x · Cited by 55
Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: Consequences in bioavailability and activities
Delmas, D., & Lin, H. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100065 · Cited by 53
Association of habitual dietary resveratrol exposure with the development of frailty in older age: the Invecchiare in Chianti study
Rabassa, M., Zamora‐Ros, R., Urpí-Sardà, M., Bandinelli, S., Ferrucci, L., Andrés‐Lacueva, C., & Cherubini, A. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.118976 · Cited by 53
Dietary supplement based on stilbenes: a focus on gut microbial metabolism by the in vitro simulator M-SHIME®
Giuliani, C., Marzorati, M., Innocenti, M., Vilchez‐Vargas, R., Vital, M., Pieper, D. H., de Wiele, T. V., & Mulinacci, N. (2016) · Food & Function · doi:10.1039/c6fo00784h · Cited by 52
Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells
Storniolo, C. E., & Moreno, J. J. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.03.036 · Cited by 51
The obese gut microbiome across the epidemiologic transition
Dugas, L. R., Fuller, M. H., Gilbert, J. A., & Layden, B. T. (2016) · Emerging Themes in Epidemiology · doi:10.1186/s12982-015-0044-5 · Cited by 50
Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- ando-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog
Dong, L., Dai, F., Sun, L., & Zhou, B. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500297 · Cited by 46
The Herbal Drug Melampyrum pratense L. (Koch): Isolation and Identification of Its Bioactive Compounds Targeting Mediators of Inflammation
Vogl, S., Atanasov, A. G., Binder, M., Bulusu, M. A. R. C., Zehl, M., Fakhrudin, N., Heiß, E. H., Picker, P., Wawrosch, C., Saukel, J., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/395316 · Cited by 41
Determination of Dihydroresveratrol in Rat Plasma by HPLC
Juan, M. E., Alfaras, I., & Planas, J. M. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100836j · Cited by 37
Evaluation of urinary resveratrol as a biomarker of dietary resveratrol intake in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Zamora‐Ros, R., Rothwell, J. A., Achaintre, D., Ferrari, P., Boutron‐Ruault, M., Mancini, F. R., Affret, A., Kuhn, T. E., Katzke, V. A., Boeing, H., et al. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517001465 · Cited by 31
Stilbene Analogs of Resveratrol Improve Insulin Resistance through Activation of AMPK
Ito-Nagahata, T., KURIHARA, C., Hasebe, M., ISHII, A., Yamashita, K., IWABUCHI, M., Sonoda, M., Fukuhara, K., Sawada, R., Matsuoka, A., et al. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.121000 · Cited by 27
Resveratrol is cidal to both classes of Haemophilus ducreyi
Nawrocki, E. M., Bedell, H. W., & Humphreys, T. L. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.008 · Cited by 19

Sorted by citations

Health benefits of polyphenols: A concise review
Rana, A., Samtiya, M., Dhewa, T., Mishra, V., & Aluko, R. E. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14264 · Cited by 840
Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota–Immune System Interplay. Implications for Health and Disease
Montero, C. G., Fraile‐Μartinez, O., Gomez-Lahoz, A. M., Pekarek, L., Castellanos, A. J., Noguerales-Fraguas, F., Coca, S., Guijarro, L. G., García‐Honduvilla, N., Asúnsolo, Á., et al. (2021) · Nutrients · doi:10.3390/nu13020699 · Cited by 487
Resveratrol Attenuates Oxidative Stress-Induced Intestinal Barrier Injury through PI3K/Akt-Mediated Nrf2 Signaling Pathway
Zhuang, Y., Wu, H., Wang, X., He, J., He, S., & Yin, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7591840 · Cited by 335
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases
Corrêa, T. A. F., Rogero, M. M., Hassimotto, N. M. A., & Lajolo, F. M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00188 · Cited by 327

See all 136

Authors: Bird, J. K., Raederstorff, D., Weber, P., & Steinert, R. E.
Affiliations: University Hospital Zurich (CH)
Corresponding author: Bird, Julia K
ORCID: Bird, Julia K
Steinert, Robert E
Venue: Advances in Nutrition
Publisher: Elsevier BV
Published: 2017-11
Volume: 8
Issue: 6
Pages: 839-849
ISSN: 2156-5376 (ISSN-L)
2161-8313
DOI: 10.3945/an.117.016568
PMC: PMC5682996
OpenAlex: W2773619793
Cited by: 136
References: 91
Citations by year: 2026: 7 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 19 · 2020: 17 · 2019: 19 · 2018: 17
FWCI: 1.66
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1548 d)
Locations: Advances in Nutrition (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
RERO DOC (Universität Bern) (submittedVersion)
CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Zurich Open Repository and Archive (University of Zurich)
Topics: Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
Keywords: resveratrol, gut microbiota, cardiovascular health, anti-obesity, first-pass metabolism, bioavailability, microbial transformation, intestinal barrier, tight junctions, Firmicutes/Bacteroidetes ratio, high-fat diet, trimethylamine N-oxide, serum cholesterol, satiety hormones, energy metabolism
MeSH terms: Gastrointestinal Microbiome, Resveratrol, Animals, Cardiovascular Diseases, Energy Metabolism, Humans, Intestinal Mucosa, Obesity, Stilbenes, Anti-Obesity Agents, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks